None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals of either sex above 18 and below 68 years 2. Population as described in High/Moderate/Low Risk 3. Individuals who are from the identified containment zone/ quarantine facility with at least 1 confirmed COVID-19 positive case. 4. Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study
Exclusion criteria
Exclusion criteria: 1. Persons with severe primary respiratory disease or related complications that may be identified with COVID-19 2. Laboratory confirmed COVID-19 with or without symptoms 3. Pregnant and lactating mothers and those who have a pregnancy plan. 4. Persons with serious critical illness, or severe mental illnesses 5. Individuals with uncontrolled, unstable comorbidities 6. Immunocompromised individuals or those on immunosuppressants and steroids 7. Subjects having a past history of allergy to any medicine that is part of the Unani intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of COVID-19 cases in control as well in interventional group 2.Improvement in immune status using Immune Status Questionnaire (ISQ) Timepoint: 20days | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Central Council for Research in Unani Medicine (CCRUM)